Abiopharma

News list

Director Foster Byron S. 🟢 acquired 347 shares (1 derivative) of DANA Inc (DAN) Transaction Date: Aug 28, 2026 | Filing ID: 007507

Full text

News bot Sept. 2, 2026, 1:24 p.m.
🔍 Foster Byron S. (Director)

Company: DANA Inc (DAN)

Report Date: 2026-08-28
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 347
Detailed Transactions and Holdings:
- Acquired 347 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-08-28 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,761.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
Footnotes:
- F1: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.